Search hospitals > Pennsylvania > Pittsburgh

University of Pittsburgh Medical Center

Claim this profile
Pittsburgh, Pennsylvania 15213
Global Leader in Cancer
Global Leader in Heart Failure
Conducts research for High Blood Pressure
Conducts research for Fibrosing Colonopathy
Conducts research for Non-Small Cell Lung Cancer
1068 reported clinical trials
124 medical researchers
Photo of University of Pittsburgh Medical Center in PittsburghPhoto of University of Pittsburgh Medical Center in Pittsburgh

Summary

University of Pittsburgh Medical Center is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, Heart Failure, High Blood Pressure, Fibrosing Colonopathy, Non-Small Cell Lung Cancer and other specialties. University of Pittsburgh Medical Center is involved with conducting 1,068 clinical trials across 1,254 conditions. There are 124 research doctors associated with this hospital, such as Liza C. Villaruz, Jason Luke, MD, Diwakar Davar, MD, and Adam Brufsky, MD.

Area of expertise

1Cancer
Global Leader
University of Pittsburgh Medical Center has run 63 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
FGFR3 positive
2Heart Failure
Global Leader
University of Pittsburgh Medical Center has run 41 trials for Heart Failure. Some of their research focus areas include:
Stage III

Top PIs

Clinical Trials running at University of Pittsburgh Medical Center

Breast Cancer
Cancer
Small Cell Lung Cancer
Chronic Pancreatitis
Age-Related Macular Degeneration
Lung Cancer
Non-Small Cell Lung Cancer
Chronic Pain
Fungal Infection
Ovarian Cancer
Image of trial facility.

Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib

for Breast Cancer

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Stopping Anti-HER2 Therapy

for Breast Cancer

This study is being done to see if anti-HER2 treatment be safely stopped in patients with HER2-positive metastatic breast cancer (MBC) that have had exceptional response to treatment. Exceptional response" is considered as cancer progression being controlled for three years or more since starting anti-HER2 treatment.
Recruiting1 award Phase 213 criteria
Image of trial facility.

PC14586

for Solid Tumors

This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Pittsburgh Medical Center?
Where is University of Pittsburgh Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Pittsburgh Medical Center accept?
What awards or recognition has University of Pittsburgh Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security